United States· US:61269-480_c70cbfa5-6b69-4fd4-8ad0-e819c8795746

Valcyte

A valganciclovir product containing valganciclovir hydrochloride, registered in United States by H2-Pharma, LLC. The same ATC class is registered in 18 of our 19 countries.

ATC J05AB14US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about valganciclovir hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valganciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
11 of them publish a price we can compare per daily dose

Search valganciclovir products by name

Valganciclovir · ATC J05AB14

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valganciclovir costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.

United States: $3.83 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Valganciclovir · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

IT Italy$35.27
CH Switzerland$35.18
FR France$22.39
US United States$3.83 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: VALGANCICLOVIR HYDROCHLORIDE
Manufacturer: H2-Pharma, LLC
Country: United States (US)
ATC code: J05AB14
ATC class: Valganciclovir
Defined daily dose: 0.9 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
61269-480-60
ndc11
6126948060
1 BOTTLE, PLASTIC in 1 CARTON (61269-480-60) / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for valganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valganciclovir against other medicines How interaction checks work

Valganciclovir · interactions on record

283 records

8 severe
193 moderate
82 info

Most severe, free to view

CladribineL01BB04severe
TrospiumA03AB20moderate
Amphotericin BA07AA07moderate
TrospiumG04BD09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valganciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Valcyte, Valganciclovir +pharma
Belgium · Valcyte, Valganciclovir Sandoz
Bulgaria · Алваноцит, Валцит
Cyprus · Valcyte, Valganciclovir Accord
Czechia · Cytevix, Valcyte
Germany · Valcyte, Valganaxiro
Denmark · Valcyte, Valganciclovir "medical Valley"
Estonia · Valganciclovir Accord, Valganciclovir Sandoz
Spain · Valcyte, Valganciclovir Accord
Finland · Valcyte, Valganciclovir Accord
France · Rovalcyte, Valganciclovir Accord
United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
Greece · Vagotrosin, Valcyte
Croatia · Alvanocyt, Valcyte
Hungary · Valcyte, Valdamin
Ireland · Valcyte, Valganciclovir Accord Healthcare
Iceland · Valcyte, Valganciclovir Medical Valley
Italy · Valcyte, Valganciclovir Accord
Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
Luxembourg · Valcyte
Latvia · Valcyte, Valganciclovir Accord
Netherlands · Alvanocyt, Valcyte
Norway · Valcyte, Valganciclovir Accord
Poland · Ceglar, Valcyte
Portugal · Rovalcyte, Valganciclovir Accord
Romania · Valganciclovir Zentiva
Sweden · Valcyte, Valganciclovir Accord
Slovenia · Ganaxa, Valcyte
Slovakia · Valdamin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/41d783a1-eaf8-46a5-93ff-718f4c46c4ec
GET /v1/drugs/41d783a1-eaf8-46a5-93ff-718f4c46c4ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "450",
  "substance": "VALGANCICLOVIR HYDROCHLORIDE",
  "productndc": "61269-480",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA021304",
  "marketing_category": "NDA"
}

API reference MCP server Plans

See everything about valganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console